ARQ (NASDAQ:ARQ – Get Free Report) and ASP Isotopes (NASDAQ:ASPI – Get Free Report) are both small-cap business services companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.
Earnings and Valuation
This table compares ARQ and ASP Isotopes’ top-line revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
ARQ | $99.18 million | 2.69 | -$12.25 million | ($0.50) | -15.94 |
ASP Isotopes | $430,000.00 | 423.21 | -$16.29 million | ($0.49) | -7.59 |
ARQ has higher revenue and earnings than ASP Isotopes. ARQ is trading at a lower price-to-earnings ratio than ASP Isotopes, indicating that it is currently the more affordable of the two stocks.
Volatility and Risk
Profitability
This table compares ARQ and ASP Isotopes’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
ARQ | -12.35% | -8.35% | -6.16% |
ASP Isotopes | N/A | -129.25% | -95.89% |
Analyst Ratings
This is a summary of current ratings and price targets for ARQ and ASP Isotopes, as provided by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
ARQ | 0 | 0 | 0 | 0 | N/A |
ASP Isotopes | 0 | 0 | 1 | 0 | 3.00 |
ASP Isotopes has a consensus target price of $5.50, suggesting a potential upside of 47.85%. Given ASP Isotopes’ higher possible upside, analysts clearly believe ASP Isotopes is more favorable than ARQ.
Insider & Institutional Ownership
18.5% of ARQ shares are held by institutional investors. Comparatively, 16.8% of ASP Isotopes shares are held by institutional investors. 22.2% of ARQ shares are held by insiders. Comparatively, 26.3% of ASP Isotopes shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Summary
ASP Isotopes beats ARQ on 8 of the 13 factors compared between the two stocks.
About ARQ
Arq, Inc. produces activated carbon products in North America. The company's products include granular activated carbon, powdered and granular activated carbon, and colloidal carbon products; Arq Powder Wetcake, a fine and low-ash coal waste-derived particle; and additives for air emissions control. Its products are used in various applications, including water treatment, ground water remediation, soil sediments, air emissions, and asphalt additives. The company was formerly known as Advanced Emissions Solutions, Inc. and changed its name to Arq, Inc. in February 2024. Arq, Inc. was founded in 1997 and is headquartered in Greenwood Village, Colorado.
About ASP Isotopes
ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.
Receive News & Ratings for ARQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARQ and related companies with MarketBeat.com's FREE daily email newsletter.